Related Experiment Video

Updated: Jun 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Acute infection-inflammation and coronary stent thrombosis: an observational study

Stefano Del Pace1, Maria Boddi, Raffaele Rasoini

  • 1Department of Heart and Vessels, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Viale Morgagni 85, 50134, Florence, Italy.

Internal and Emergency Medicine
|February 20, 2010
PubMed

Insights

Acute infection-inflammation may trigger coronary stent thrombosis (CST) in patients with fewer known risk factors. This suggests new prevention strategies targeting inflammation could be beneficial for CST management.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Inflammation and Immunology

Background:

  • Coronary stent thrombosis (CST) remains a significant complication in interventional cardiology.
  • Existing risk factors do not fully elucidate the underlying pathophysiology of CST.
  • The potential role of acute infection-inflammation in precipitating CST requires further investigation.

Purpose of the Study:

  • To investigate the association between acute infection-inflammation and the occurrence of CST.
  • To identify clinical characteristics and risk factors in patients experiencing CST.
  • To explore the inflammatory status in patients admitted for CST.

Main Methods:

  • Retrospective analysis of 41 patients admitted for CST.
  • Diagnosis of acute infection-inflammation based on predefined criteria.
  • Assessment of known CST risk factors, inflammatory markers, and clinical parameters.

Main Results:

  • 51% of patients with CST presented with acute infection-inflammation.
  • Patients with infection-inflammation showed elevated inflammatory markers and a lower prevalence of known risk factors.
  • These patients also exhibited more frequent antiplatelet treatment interruption, longer stent length, and reduced left ventricular ejection fraction.

Conclusions:

  • Acute infection-inflammation may facilitate CST in a subset of patients with a low-risk profile for traditional factors.
  • Findings suggest potential new avenues for CST prevention and treatment by addressing inflammatory triggers.
  • Further research is warranted to confirm these observations and their clinical implications.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...